Congress Introduces Bill to Expand CISA’s Role in Safeguarding Biotechnology

Lawmakers in both the House and Senate have introduced legislation that would task the Cybersecurity and Infrastructure Security Agency (CISA) with strengthening cyber defenses for the biotechnology sector, a field that currently falls outside the federal government’s 16 designated critical infrastructure categories.

Under the existing framework, agencies such as the Department of Homeland Security focus specialized resources on sectors like energy, water, and communications. Biotechnology, despite its growing importance to public health and the national economy, is not formally recognized as a critical infrastructure asset, leaving it without the same level of coordinated federal protection.

The push for new legislation comes amid a wave of cyber incidents targeting biotech firms, including ransomware attacks that have disrupted laboratory operations and theft of proprietary research data. Analysts note that the sector’s reliance on high‑value intellectual property and its role in vaccine and drug development make it an attractive target for nation‑state actors and criminal groups alike.

Proposed provisions would grant CISA broader authority to share threat intelligence with biotech companies, develop sector‑specific security guidelines, and require timely reporting of significant cyber events. The bill also calls for the creation of a dedicated liaison office within CISA to coordinate response efforts and facilitate public‑private partnerships aimed at hardening digital defenses.

Supporters argue that the legislation fills a glaring gap in the nation’s cyber‑risk management strategy, emphasizing that a breach in biotech could have downstream effects on medical supply chains and public health. Critics caution that expanding federal oversight must be balanced with protecting proprietary information and maintaining industry innovation.

The measures are slated for review by the House Energy and Commerce Committee and the Senate Homeland Security and Governmental Affairs Committee later this year. If enacted, the law could pave the way for formal recognition of biotechnology as a critical infrastructure sector, aligning its cybersecurity posture with that of other high‑risk industries.